Argenx
ARGX
#579
Rank
C$50.62 B
Marketcap
$827.96
Share price
0.77%
Change (1 day)
24.48%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: C$50.62 Billion

As of November 2024 Argenx has a market cap of C$50.62 Billion. This makes Argenx the world's 579th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024C$50.62 B69.15%
2023C$29.93 B5.25%
2022C$28.43 B21.34%
2021C$23.43 B31.09%
2020C$17.87 B99.01%
2019C$8.98 B88.1%
2018C$4.77 B89.48%
2017C$2.52 B
2014C$0.16 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Argenx was reported to be:

C$49.50 Billion
by Yahoo Finance info icon info icon
C$50.62 Billion
by CompaniesMarketCap info icon info icon
C$49.01 Billion
by Nasdaq info icon info icon